20234 ⎘
Medicinal preparations containing organic active ingredients; Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or , e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
MODULATORS OF RAR RELATED ORPHAN RECEPTORS (RORs)
#2AZOLE DERIVATIVES AS SHP2 INHIBITORS
#3CANNABINOID ANALOGS AND METHODS OF USE FOR TREATMENT AND PREVENTION OF CANCER
#4METHODS OF TREATING GRADE 3 ASTROCYTOMA
#5COMPOSITIONS AND METHODS FOR ENHANCING OR IMPROVING BLOOD FLOW IN A SUBJECT
#6METHODS OF TREATING GLIOBLASTOMA WITH PRODRUGS OF RILUZOLE
#7METHODS FOR TREATING TUMORS
#8AN INJECTABLE MICROPARTICLE SYSTEM AND METHOD OF PREPARING THEREOF
#9METHODS OF POTENTIATING TEMOZOLOMIDE ACTIVITY AGAINST GLIOBLASTOMA CELLS
#10ALBUMIN CONJUGATES AND RADIOPHARMACEUTICAL COMPOSITION THEREOF
#11METHODS AND COMPOSITIONS FOR DELIVERY OF IMMUNOTHERAPY AGENTS ACROSS THE BLOOD-BRAIN BARRIER TO TREAT BRAIN CANCER
#12COMPOSITIONS AND METHODS FOR USE OF EFLORNITHINE AND DERIVATIVES AND ANALOGS THEREOF TO TREAT CANCERS, INCLUDING GLIOMAS
#13N-SUBSTITUTED C6 CYCLYL CARBOXAMIDE COMPOUNDS AND USES THEREOF
#14Methods related to opioid therapeutics
#15Theramutein modultors
#16ANTISENSE OLIGONUCLEOTIDES FOR THEIR USE IN AN ANTI-CANCER TREATMENT
#17Methods For The Effective Treatment Of Metastatic Cancer
#18COMPOUNDS AND METHODS TO TARGET GLUCOSE-STIMULATED PHOSPHOHISTIDINE SIGNALING AND ESOPHAGEAL CANCER GROWTH
#19METHODS FOR TREATING DISEASES MEDIATED BY GLUTATHIONE PEROXIDASE 4
#20COMBINATION OF IMMUNOTHERAPY WITH LOCAL CHEMOTHERAPY FOR THE TREATMENT OF MALIGNANCIES
#21THERAPEUTIC AGENTS AND METHODS
#22TARGETING ZNF410 FOR FETAL HEMOGLOBIN INDUCTION IN BETAHEMOGLOBINOPATHIES
#23Method For Treating Pancreatic Cancer
#24COMPOUNDS FOR USE IN THE TREATMENT OF SYNUCLEINOPATHIES
#25Stable ready-to-use carmustine pharmaceutical composition
#26COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTRACELLULAR BACTERIAL INFECTIONS
#27COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTRACELLULAR BACTERIAL INFECTIONS
#28Methods and compositions for delivery of immunotherapy agents across the blood-brain barrier to treat brain cancer
#29N-(FURAN-2-YLMETHYL)-7H-PURIN-6-AMINE FOR TREATMENT OF CIRCADIAN RHYTHM DISEASES, DISORDERS AND DYSFUNCTIONS
#30DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#31Drug Formulations and Methods of Treatment for Metabolic Disorders
#32SHORTENING TUBERCULOSIS THERAPY AND REDUCING RELAPSE BY CO-ADMINISTERING CHLOROQUINE IN TB AND HIV-TB COINFECTED CONDITIONS
#33Theramutein modulators
#34Theramutein modulators
#35Therapeutic agents and methods
#36Methods and compositions for diagnosing and treating glaucoma
#37INHIBITATION OF ACID LIPASE FOR CANCER THERAPY
#38METHODS OF TREATING CANCER
#39DISULFIDE-MASKED PRO-CHELATOR COMPOSITIONS AND METHODS OF USE
#40METHODS OF TREATING BREAST CANCER
#41THERAPEUTIC AGENT FOR CORNEAL DISEASES
#42THIENO[2,3-D)PYRIMIDINES AND BENZOFURO(3,2-D)PYRIMIDINES AS ANTIMICROBIAL AGENTS
#43Therapeutic agents and methods
#44Methods related to opioid therapeutics
#45STABLE READY-TO-USE CARMUSTINE PHARMACEUTICAL COMPOSITION
#46Methods and apparatuses for treating tumors
#47FORMULATIONS AND METHODS FOR LYOPHILIZATION AND LYOPHILATES PROVIDED THEREBY
#48FORMULATIONS FOR A TIGHT JUNCTION EFFECTOR
#49COMPOSITION CONTAINING GLIBENCLAMIDE
#50DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#51COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ATYPICAL BRAF MUTATIONS
#52Combination of immunotherapy with local chemotherapy for the treatment of malignancies
#53Theramutein modulators
#54Theramutein modulators
#55Methods and compositions for diagnosing and treating glaucoma
#56Use of formin agonists in overcoming brain tumor radio- and chemo-resistance by targeting tumor microtubes
#57Compositions and related methods for reconstituting the immune system of a subject
#58DISULFIDE-MASKED PRO-CHELATOR COMPOSITIONS AND METHODS OF USE
#59THERAPEUTIC AGENTS TARGETING THE NCCa-ATP CHANNEL AND METHODS OF USE THEREOF
#60NEW TREATMENT OF BRAIN CANCER
#61KIT FOR PREPARING INJECTABLE CARMUSTINE SOLUTIONS
#62Composition containing glibenclamide
#63Formulations and methods for lyophilization and lyophilates provided thereby
#64Pharmaceutical compounds and uses thereof
#65METHODS FOR TREATING OR PREVENTING FATIGUE
#66Theramutein modulators
#67DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#68Therapeutic agents and methods
#69Antimicrobial peptide, its analog and use
#70Lipid formulations of carmustine
#71Carmustine pharmaceutical composition
#72(Thio, oxo and seleno) semicarbazone complexes with zinc and their use for treating cancer
#73Methods for the effective treatment of metastatic cancer
#74Treatment for glioblastoma
#75Therapeutic agent for diabetes
#76Anti-fibulin-3 antibodies and uses thereof
#77COMPOSITIONS AND METHODS FOR USE OF EFLORNITHINE AND DERIVATIVES AND ANALOGS THEREOF TO TREAT CANCERS, INCLUDING GLIOMAS
#78Multi-tiered high through-put screen for compounds effective against bacterial biofilm and compounds effective for inhibiting and eradicating bacterial biofilm
#79Sequential anti-cancer treatment
#80Formulations and methods for lyophilization and lyophilates provided thereby
#81Redox-activated pro-chelators
#82Compounds and methods of treating infections
#83PARENTERAL COMPOSITIONS OF CARMUSTINE
#84Methods and compositions for increasing the anaerobic working capacity in tissues
#85CSF-1R inhibitors for treatment of brain tumors
#86PULSATILE RELEASE PHARMACEUTICAL COMPOSITION COMPRISING NAFTAZONE OR ONE OF ITS SALTS
#87NANOVECTORS FOR PENETRATING BRAIN TUMOR TISSUES TO CONDUCT GENE THERAPY
#88REDOX-ACTIVATED GLYCOCONJUGATED PROCHELATORS
#89Benzhydrol derivatives for the management of conditions related to hypoxia inducible factors
#90Composition containing glibenclamide
#91Methods for treating or preventing fatigue using O-carbamoyl-phenylalaninol compounds
#92Adjuvant chemotherapy for anaplastic gliomas
#93DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#94METHODS FOR TREATING NEURAL CELL SWELLING
#95Methods for the Effective Treatment of Metastatic Cancer
#96Theramutein modulators
#97(Thio, oxo, and seleno) semicarbazone derivatives and their use for treating cancer
#98(Thio, oxo, and seleno) semicarbazone complexes with zinc and their use for treating cancer
#99TRANSDERMAL PARASITICIDAL FORMULATIONS
#100Methods for treating central or peripheral nervous system damage
#101Class-and isoform-specific HDAC inhibitors and uses thereof
#102Theramutein modulators
#103REDOX-DIRECTED CHELATORS TARGETING INTRACELLULAR METAL IONS
#104Thiosemicarbazones inhibitors of lysophosphatidic acid acyltransferase and uses thereof
#105Adjuvant chemotherapy for anaplastic gliomas
#106Anti-fibulin-3 antibodies and uses thereof
#107Methods for treating or preventing fatigue
#108Combination of immunotherapy with local chemotherapy for the treatment of malignancies
#109Adamantane or pinene derivatives for use in the treatment of chlamydiales infections
#110Carmustine pharmaceutical composition
#111Compounds and methods of treating infections
#112Pesticidal compositions and processes related thereto
#113Methods and compositions for increasing the anaerobic working capacity in tissues
#114Pesticidal compositions and processes related thereto
#115Multi-tiered, high through-put screen for compounds effective against bacterial biofilm compounds effective for inhibiting and eradicating bacterial biofilm
#116Oral antiseptic composition useful for treating oral mucositis
#117Compounds that inhibit human DNA ligases and methods of treating cancer
#118Class- and isoform-specific HDAC inhibitors and uses thereof
#119Transdermal parasiticidal formulations
#120Methods for the Effective Treatment of Metastatic Cancer
#121Compounds for use in the treatment of mycobacterial infections
#122Formulations and methods for lyophilization and lyophilates provided thereby
#123Redox-directed chelators targeting intracellular metal ions
#124Tyrosinase inhibitors
#125Androgen receptor ligands
#126Compositions and methods for treating obesity, obesity related disorders and for inhibiting the infectivity of human immunodeficiency virus
#127Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
#128Methods for treating or preventing fatigue
#129Methods for treating neural cell swelling
#130Adjuvant chemotherapy for anaplastic gliomas
#131Pesticidal compositions and processes related thereto
#132Pesticidal compositions and processes related thereto
#133Uses of NANOG inhibitors and related methods
#134Methods and compounds for treating cancer
#135Compounds that inhibit human DNA ligases and methods of treating cancer
#136CSF-1R INHIBITORS FOR TREATMENT OF BRAIN TUMORS
#137GPR35 Ligands And Uses Thereof
#138Sustained-release polymeric microparticles containing poorly water-soluble drug and method for preparing the same
#139Methods and compositions for increasing the anaerobic working capacity in tissues
#140Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses
#141Formulations and methods for lyophilization and lyophilates provided thereby
#142Method for treating celiac disease
#143Co-Therapy for Diabetic Conditions
#144METHODS FOR TREATING NEURAL CELL SWELLING
#145METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISORDERS OF GLUCOSE HOMEOSTASIS
#146Class- and isoform-specific HDAC inhibitors and uses thereof
#147Methods and compositions for increasing the anaerobic working capacity in tissues
#148COMBINED TREATMENT OF CANCER BY UROKINASE INHIBITION AND A CYTOSTATIC ANTI-CANCER AGENT FOR ENHANCING THE ANTI-METASTATIC EFFECT
#149Methods for treating or preventing fatigue
#150LOCALIZED THERAPY FOLLOWING BREAST CANCER SURGERY
#151Alkylating agent combinations in the treatment of cancer
#152TRP-P8 ACTIVE COMPOUNDS AND THERAPEUTIC TREATMENT METHODS
#153Combination of local temozolomide with local BCNU
#154Methods and compositions for increasing the anaerobic working capacity in tissues
#155METHODS OF TREATING INFLAMMATORY DISORDERS
#156Method of treating inflammation with statins
#157Compositions and methods for ophthalmic delivery of nasal decongestants
#158Compositions and methods for treating obesity, obesity related disorders and for inhibiting the infectivity of human immunodeficiency virus
#159Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
#160Modulation of pathogenicity
#161Methods for treating spinal cord injury with a compound that inhibits a NCCA-ATP channel
#162SYSTEM AND METHOD FOR ELECTROSPUN DRUG LOADED BIODEGRADABLE CHEMOTHERAPY APPLICATIONS
#163Methods and compositions for increasing the anaerobic working capacity in tissues
#164Modulation of Pathogenicity
#165Modulation of pathogenicity
#166Method for treating celiac disease
#167Formulations and methods for lyophilization and lyophilates provided thereby
#168Co-Therapy For Diabetic Conditions
#169Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
#170PHARMACEUTICAL COMPOSITIONS COMPRISING SEMICARBAZONES AND THIOSEMICARBAZONES AND METHOD FOR TREATING INFLAMMATORY, PAINFUL AND FEBRILE CONDITIONS AND PREVENTING SIGNS AND SYMPTOMS OF INFLAMMATION
#171Combination of organic compounds useful for treating diabetes
#172Compounds that inhibit human DNA ligases and methods of treating cancer
#173Adjuvant chemotherapy for anaplastic gliomas
#174Use of Chk2 kinase inhibitors for cancer treatment
#175COMBINATION WITH BIS (THIOHYDRAZIDE AMIDES) FOR TREATING CANCER
#176Treatment of Alzheimer's Disease Using Compounds that Reduce the Activity of Non Selective Ca Activated ATP- Sensitive Cation Channels Regulated by SUR1 Receptors
#177COMPOSITIONS FOR MANIPULATING THE LIFESPAN AND STRESS RESPONSE OF CELLS AND ORGANISMS
#178Thiosemicarbazones as anti-virals and immunopotentiators
#179NOVEL MEMORY CTL INDUCTION POTENTIATOR
#180Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses
#181Combination of FBPase Inhibitors and Antidiabetic Agents Useful for the Treatment of Diabetes
#182INHIBITORS OF NITRIC OXIDE SYNTHASE
#183PHARMACEUTICAL COMPOSITION FOR SUPPRESSION OF THE EXPRESSION OF ATP CITRATE LYASE AND USE THEREOF
#184NOVEL NON-SELECTIVE CATION CHANNEL IN NEURONAL CELLS AND METHOD FOR TREATING BRAIN SWELLING
#185Therapeutic methods that target the NCchannel
#186Modulation of pathogenicity
#187Compositions and methods for treating obesity, obesity related disorders and for inhibiting the infectivity of human immunodeficiency virus
#188Antisense Modulation of PTP1B Expression
#189Methods and compositions for increasing the anaerobic working capacity in tissues
#190Sodium Channel Blocker Compositions and the Use Thereof
#191THERAPEUTIC USES OF AN INSULIN SECRETION ENHANCER
#192METHODS OF TREATING JUVENILE TYPE 1 DIABETES MELLITUS
#193Therameutin modulators
#194SMALL PARTICLE LIPOSOME AEROSOLS FOR DELIVERY OF ANTI-CANCER DRUGS
#195Combined treatment of cancer by urokinase inhibition and a cytostatic anti-cancer agent for enhancing the anti-metastatic effect
#196Modulation of pathogenicity
#197Combinations of Chromium with Antidiabetics for Glucose Metabolism Disorders
#198Modulation of pathogenicity
#199Modulation of pathogcnicity
#200Modulation of pathogenicity
#201Modulation of pathogenicity
#202Modulation of pathogenicity
#203Modulation of pathogenicity
#204Modulation of pathogenicity
#205Methods for treating neural cell swelling
#206COMPOSITION AND METHOD FOR SUPPORTING THERMOGENESIS AND LIPID OXIDATION
#207Composition containing statins and omega-3 fatty acids
#208Pharmaceutical compositions of semicarbazones and/or thiosemicarbazones and/or their derivatives and products of these compositions and their uses as anticonvulsant, anti-nociceptive and anti-inflammatory agents, and in the angiogenic therapy
#209Methods and compositions for the treatment of neurodegenerative disorders
#210Combinations of vanadium with antidiabetics for glucose metabolism disorders
#211Combined Use of Derivatives of GLP-1 Analogs and PPAR Ligands
#212Combinations of chromium with antidiabetics for glucose metabolism disorders
#213Methods for the prevention and/or the treatment of glutamate cytotoxicity
#214Methods for the prevention and/or the treatment of glutamate cytotoxicity
#215Methods for the prevention and/or the treatment of glutamate cytotoxicity
#216Combinations of vanadium with antidiabetics for glucose metabolism disorders
#217Combinations of chromium with antidiabetics for glucose metabolism disorders
#218Combinations of vanadium with antidiabetics for glucose metabolism disorders
#219Formulations for a tight junction effector
#220Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
#221Methods for identifying modulators of kinesin activity
#222COMBINATION OF ORGANIC COMPOUNDS
#223Combinations of chromium with antidiabetics for glucose metabolism disorders
#224Use of compounds
#225Methods for treating diabetes and related disorders using pde10a inhibitors
#226Pharmaceutical composition and method for the treatment of diseases using HMG-CoA reductase inhibitors and insulin secretion enhancers or sensitizers
#227Inhibitors of nitric oxide synthase to treat type 1 diabetes
#228Anorectic
#229Co-therapy for diabetic conditions
#230METHODS OF USING ACYL HYDRAZONES AS sEH INHIBITORS
#231Treatment and Diagnosis of Insulin-Resistant States
#232Synergistic cinnamon combinations and methods for enhancing insulin activity
#233Pharmaceutical compositions of an AT-receptor antagonist and an insulin secretion enhancer
#234Methods for treating brain swelling with a compound that blocks a non-selective cation channel
#235Versatile high load concentrate compositions for control of ecto- parasites
#236Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same
#237Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
#238Method of reducing drug-induced adverse side effects in a patient
#239Use of a peptide
#240Use of a peptide
#241Alkylating agent combinations in the treatment of cancer
#242Methods for the treatment of insulin resistance and disease states characterized by insulin resistance
#243Treatment of Human Multiple Myeloma by Curcumin
#244Process for producing nanoparticles by spray drying
#245Methods of treating ischemic related conditions
#246Treatment of cell proliferative disorders with chlorotoxin
#247Treatment of glioblastoma with thymosin-alpha 1
#248Combined treatment with interferon-alpha and an epidermal growth factor receptor kinase inhibitor
#249Use of compounds
#250Antiviral treatment
#251Compound useful in the treatment or prevention of cognitive disorders associated with diabetes and associated methods
#252Activators and inhibitors of protease activated receptor2 (PAR2) and methods of use
#253Methods for treating spinal cord injury with a compound that inhibits a NCchannel
#254Sustained release drug delivery system and method
#255Combination
#256Antisense modulation of PTP1B expression
#257Compositions for manipulating the lifespan and stress response of cells and organisms
#258Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
#259Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
#260Combined use of derivatives of GLP-1 analogs and PPAR ligands
#261Combinations of chromium or vanadium with antidiabetics
#262Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
#263Combination therapy comprising a Cox-2 inhibitor and an antineoplastic agent
#264Combination therapy with inhibitors of inducible nitric oxide synthase and alkylating agents
#265Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
#266Process to prepare semicarbazones' and/or tiosemicarbazones' formulations using cyclodextrins and their derivatives and products obtained by this process
#267Methods for treating neural cell swelling
#268Treatment and diagnosis of insulin-resistant states
#269Method of screening compounds
#270Cinnamon formulation for reducing cholesterol and/or glucose levels
#271Prophylactic and therapeutic agent of diabetes mellitus
#272Compositions for manipulating the lifespan and stress response of cells and organisms
#273Use of small molecule compounds for immunopotentiation
#274HIV protease inhibiting compounds
#275Polyhydroxylated benzene-containing compounds
#276Dosing regimen for ppar-gamma activators
#277Combination of organic compounds
#278Pharmaceutical compositions and methods for treating, preventing, and managing cholesterol, dyslipidemia, and related disorders
#279Pharmaceutical composition for suppression of the expression of ATP citrate lyase and use thereof
#280Compositions for manipulating the lifespan and stress response of cells and organisms
#281Trp-p8 active compounds and therapeutic treatment methods
#282Thiosemicarbazones as anti-virals and immunopotentiators
#283Bactericidal antimicrobial methods and compositions for use in treating gram positive infections
#284Use of compounds
#285Agents for Treating Diseases Caused by Nonsense Mutations